Barbara Malene Fischer
Clinical trials sponsored by Barbara Malene Fischer, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan could spot hidden cancers faster and more accurately Results expected Jan 2027 (estimated)
-
New scan could spot hidden cancers faster and more accurately
Diagnosis Recruiting nowThis study tests a new type of PET/CT scan (using [68Ga]Ga-FAPI-46) to see if it can find and stage gastroesophageal and pancreatic cancers better than current scans. About 90 adults with these cancers will get the new scan before surgery or treatment, and some will have a second…
Phase 2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New PET scan tracer could sharpen view of melanoma treatment response
Diagnosis Recruiting nowThis phase 2 trial is testing whether a new radioactive tracer, [68Ga]Ga-FAPI-46, can improve how doctors evaluate response to immunotherapy in patients with stage IV melanoma. Twenty participants will receive two experimental PET/CT scans—one before starting immunotherapy and on…
Phase 2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC